<output id="b3vhn"></output><listing id="b3vhn"><output id="b3vhn"></output></listing><p id="b3vhn"><delect id="b3vhn"><address id="b3vhn"></address></delect></p>
<pre id="b3vhn"></pre><p id="b3vhn"><delect id="b3vhn"><address id="b3vhn"></address></delect></p><pre id="b3vhn"><delect id="b3vhn"><listing id="b3vhn"></listing></delect></pre>

<output id="b3vhn"></output><pre id="b3vhn"></pre>
<output id="b3vhn"><menuitem id="b3vhn"></menuitem></output>
<p id="b3vhn"></p>
<p id="b3vhn"></p>

<pre id="b3vhn"><delect id="b3vhn"><listing id="b3vhn"></listing></delect></pre>
<p id="b3vhn"></p>

<p id="b3vhn"></p>

<p id="b3vhn"><delect id="b3vhn"></delect></p>
<p id="b3vhn"><output id="b3vhn"></output></p>
<p id="b3vhn"></p>
<pre id="b3vhn"><p id="b3vhn"><delect id="b3vhn"></delect></p></pre>
<pre id="b3vhn"></pre>

<p id="b3vhn"><menuitem id="b3vhn"></menuitem></p>

<pre id="b3vhn"><output id="b3vhn"><menuitem id="b3vhn"></menuitem></output></pre>

<p id="b3vhn"></p>

<noframes id="b3vhn"><p id="b3vhn"><menuitem id="b3vhn"></menuitem></p>

<p id="b3vhn"><menuitem id="b3vhn"></menuitem></p>

歡迎您訪問武漢艾美捷科技有限公司官方網站!
站點地圖 服務熱線:400-6800-868
  • 產品
  • 文章

AGENT BRAND

分子生化產品
分子生化產品

當前位置:首頁 > 代理品牌 > 分子生化產品

  • 品牌詳情
  • 品牌專題

Matriks Biotek

發布者:艾美捷科技    發布時間:2024-01-16 11:28:17     
分享到:

Matriks Biotek代理logo

Matriks Biotek官網鏈接:https://www.matriksbiotek.com/ 


Matriks Biotek公司成立于2002年,專門生產針對抗體藥的ELISA試劑盒,用于檢測抗體藥的體內濃度或因使用抗體藥而產生的抗體的體內濃度。Matriks Biotek產品達到ISO 13485 & CE IVD標準。目前,在30個國家有超過25個的大型制藥企業都在使用其產品。   


抗體藥(Monoclonal Antibody Drugs)是一類相對新型的生物制劑,是一類使用人工合成的單克隆抗體作為藥物治療的藥物??贵w藥這些抗體藥物通過特異性地結合目標分子或細胞表面受體,發揮治療作用??贵w藥物具有高度的特異性和親和力,可以選擇性地結合目標分子或細胞表面受體,從而干擾或調節生物過程。因此,檢測抗體藥血藥濃度及機體針對抗體藥產生的抗體水平對指導治療和個性化用藥具有重要意義。目前,大量的臨床和制藥企業都在從事該項研究。   


抗體藥物已被廣泛應用于多種疾病的治療,包括腫瘤、自身免疫性疾病、傳染病等。它們可以作為單獨的治療藥物使用,也可以與其他藥物聯合應用,以增強治療效果。   


作為Matriks Biotek在中國區域的代理,艾美捷科技有限公司將為中國客戶提供全面的Matriks Biotek產品。

下圖為Matriks Biotek授權艾美捷科技有限公司(AmyJet Scientific Inc.)作為Matriks Biotek在中國區域的代理授權書。  

Matriks Biotek艾美捷代理授權書

Matriks Biotek產品


Matriks Biotek特色產品推薦:

MTB-COR-QNS-IGG-SRBDCORONAHUNTER (Q-CORSRBD IgG) anti-Spike RBD IgG ELISA
MTB-COR-QNS-IGG-S1CORONAHUNTER (Q-CORS1 IgG) anti-Spike 1 IgG ELISA
MTB-COR-QNS-IGG-NCPCORONAHUNTER (Q-CORN IgG) anti-Nucleocapsid IgG  ELISA
MTB-COR-QNS-IGG-STRIMCORONAHUNTER (Q-CORS IgG) anti-S Trimer IgG ELISA
MTB-COR-QNS-IGM-SRBDCORONAHUNTER (Q-CORSRBD IgM) anti-Spike RBD IgM ELISA
MTB-COR-QNS-IGM-S1CORONAHUNTER (Q-CORS1 IgM) anti-Spike 1 IgM ELISA
MTB-COR-QNS-IGM-NCPCORONAHUNTER (Q-CORN IgM) anti-Nucleocapsid IgM  ELISA
MTB-COR-QNS-IGM-STRIMCORONAHUNTER (Q-CORS IgM) anti-S Trimer IgM ELISA
MTB-COR-QNS-IGA-SRBDCORONAHUNTER (Q-CORSRBD IgA) anti-Spike RBD IgA ELISA
MTB-COR-QNS-IGA-S1CORONAHUNTER (Q-CORS1 IgA) anti-Spike 1 IgA ELISA
MTB-COR-QNS-IGA-NCPCORONAHUNTER (Q-CORN IgA) anti-Nucleocapsid IgA ELISA
MTB-COR-QNS-IGA-STRIMCORONAHUNTER (Q-CORS IgA) anti-S Trimer IgA ELISA
MTB-COR-QNS-IGE-SRBDCORONAHUNTER (Q-CORSRBD IgE) anti-Spike RBD IgE ELISA
MTB-COR-QNS-IGE-S1CORONAHUNTER (Q-CORS1 IgE) anti-Spike 1 IgE ELISA
MTB-COR-QNS-IGE-NCPCORONAHUNTER (Q-CORN-SRBD IgE) anti-Nucleocapsid-S RBD IgE ELISA
MTB-COR-QNS-IGE-STRIMCORONAHUNTER (Q-CORS IgE) anti-S Trimer IgE ELISA
MTB-INF-FD-REMIShikari (Q-INFLIXI) Infliximab (Remicade) ELISA
MTB-INF-SPEC-INFShikari (QS-INFLIXI) Infliximab (Remicade) ELISA
MTB-INF-QLS-REMIShikari (Q-ATI) Infliximab (Remicade) ELISA
MTB-INF-QNS-REMIShikari (Q-ATI) w/confirmation Infliximab (Remicade) ELISA
MTB-INF-QNFT-REMIShikari (Q-ATIDUO) Infliximab (Remicade) ELISA
MTB-INF-FD-REMSShikari (Q-REMS) Infliximab (Remsima) ELISA
MTB-INF-QLS-REMSShikari (S-AIR) Qualitative Infliximab (Remsima) ELISA
MTB-INF-QNS-REMSShikari (S-AIR) w/confirmation Infliximab (Remsima) ELISA
MTB-INF-QNFT-REMSShikari (S-AIR) Total semiquantitative Infliximab (Remsima) ELISA
MTB-ADA-FD-HUMShikari (Q-ADA) Adalimumab (Humira) ELISA
MTB-ADA-SPEC-ADAShikari (QS-ADA) Adalimumab (Humira) ELISA
MTB-ADA-QLS-HUMShikari (S-ATA)-Qualitative Adalimumab (Humira) ELISA
MTB-ADA-QNS-HUMShikari (S-ATA) w/confirmation Adalimumab (Humira) ELISA
MTB-ADA-QNFT-HUMShikari (S-ATA)-Free/Total semiquantitative Adalimumab (Humira) ELISA
MTB-ETA-FD-ENBShikari (Q-ETA) Etanercept (Enbrel) ELISA
MTB-ETA-QLS-ENBShikari (S-ATE) Etanercept (Enbrel) ELISA
MTB-GOL-FD-SIMShikari (Q-GOL) Golimumab (Simponi) ELISA
MTB-GOL-QLS-SIMShikari (S-ATG) Golimumab (Simponi) ELISA
MTB-GOL-QNS-SIMShikari (S-ATG) w/confirmation Golimumab (Simponi) ELISA
MTB-CER-FD-CIMShikari (Q-CERT) Certolizumab (Cimzia) ELISA
MTB-CER-QNS-CIMShikari (S-ATCER) Certolizumab (Cimzia) ELISA
MTB-VED-SPEC-VEDShikari (QS-VEDO) Vedolizumab (Entyvio) ELISA
MTB-VED-FD-ENTShikari (Q-VEDO) Vedolizumab (Entyvio) ELISA
MTB-VED-QLS-ENTShikari (S-ATV) Vedolizumab (Entyvio) ELISA
MTB-VED-QNS-ENTShikari (S-ATV) w/confirmation Vedolizumab (Entyvio) ELISA
MTB-UST-FD-STEShikari (Q-UST) Ustekinumab (Stelara) ELISA
MTB-UST-SPEC-STEShikari (QS-UST) Ustekinumab (Stelara) ELISA
MTB-UST-QLS-STEShikari (S-ATU) Ustekinumab (Stelara) ELISA
MTB-UST-QNS-STEShikari (S-ATU) w/confirmation Ustekinumab (Stelara) ELISA
MTB-RAM-FD-CYRShikari (Q-RAM) Ramucirumab (Cyramza) ELISA
MTB-RAM-QLS-CYRShikari (S-ATRAM) Ramucirumab (Cyramza) ELISA
MTB-BEV-FD-AAShikari (Q-BEVA) Bevacizumab (Avastin) ELISA
MTB-BEV-QLS-AAShikari (S-ATB) Bevacizumab (Avastin) ELISA
MTB-BEV-QNS-AAShikari (S-ATB) w/confirmation Bevacizumab (Avastin) ELISA
MTB-RIT-FD-RMShikari (Q-RITUX) Rituximab (Rituxan, Mabthera) ELISA
MTB-RIT-QLS-RMShikari (S-ATR) Rituximab (Rituxan, Mabthera) ELISA
MTB-RIT-QNS-RMShikari (S-ATR) w/confirmation Rituximab (Rituxan, Mabthera) ELISA
MTB-TRA-FD-HHShikari (Q-TRAS) Trastuzumab (Herceptin, Herclon) ELISA
MTB-TRA-QLS-HHShikari (S-ATT) Trastuzumab (Herceptin, Herclon) ELISA
MTB-TRA-QNS-HHShikari (S-ATT) w/confirmation Trastuzumab (Herceptin, Herclon) ELISA
MTB-CET-FD-ERBShikari (Q-CET) Cetuximab (Erbitux) ELISA
MTB-CET-QLS-ERBShikari (S-ATC) Cetuximab (Erbitux) ELISA
MTB-CET-QNS-ERBShikari (S-ATC) w/confirmation Cetuximab (Erbitux) ELISA
MTB-DEN-FD-PROShikari (Q-DEN) Denosumab (Prolia) ELISA
MTB-DEN-QLS-PROShikari (S-ATD) Denosumab (Prolia) ELISA
MTB-DEN-QNS-PROShikari  (S-ATD) w/confirmation Denosumab (Prolia) ELISA
MTB-FIL-QNS-FRAShikari (Q-AFA) Filgrastim ELISA
MTB-OMA-FD-XOLShikari (Q-OMA) Omalizumab (Xolair) ELISA
MTB-OMA-QLS-XOLShikari (S-ATO) Omalizumab (Xolair) ELISA
MTB-RAN-FD-LUCShikari (Q-RAN) Ranibizumab (Lucentis) ELISA
MTB-AVE-FD-BAVShikari (Q-AVE) Avelumab (Bavencio) ELISA
MTB-AVE-QLS-BAVShikari (S-ATAV) Avelumab (Bavencio) ELISA
MTB-NIV-FD-OPDShikari (Q-NIVO) Nivolumab (Opdivo) ELISA
MTB-NIV-QLS-OPDShikari (S-ATN) Nivolumab (Opdivo) ELISA
MTB-NIV-QNS-OPDShikari (S-ATN) w/confirmation Nivolumab (Opdivo) ELISA
MTB-PEM-FD-KEYShikari (Q-PEM) Pembrolizumab (Keytruda) ELISA
MTB-PEM-QLS-KEYShikari (S-ATP) Pembrolizumab (Keytruda) ELISA
MTB-PEM-QNS-KEYShikari (S-ATP) w/confirmation Pembrolizumab (Keytruda) ELISA
MTB-IPI-FD-YERShikari (Q-IPI) Ipilimumab (Yervoy) ELISA
MTB-IPI-QLS-YERShikari (S-ATI) Ipilimumab (Yervoy) ELISA
MTB-IPI-QNS-YERShikari (S-ATI) w/confirmation Ipilimumab (Yervoy) ELISA
MTB-TOC-FD-ACTShikari (Q-TOC) Tocilizumab (Actemra) ELISA
MTB-TOC-QLS-ACTShikari (S-ATOC) Tocilizumab (Actemra) ELISA
MTB-TOC-QNS-ACTShikari (S-ATOC) w/confirmation Tocilizumab (Actemra) ELISA
MTB-NAT-FD-TYSShikari (Q-NAT) Natalizumab (Tysabri) ELISA
MTB-NAT-QLS-TYSShikari (S-ATNAT) Natalizumab (Tysabri) ELISA
MTB-NAT-QNS-TYSShikari (S-ATNAT) w/confirmation Natalizumab (Tysabri) ELISA
MTB-AFL-FD-EYLShikari (Q-AF) Aflibercept (Eylea) ELISA
MTB-AFL-FD-SENS-EYLShikari (Q-AF) High Sensitive Aflibercept (Eylea) ELISA
MTB-AFL-QLS-EYLShikari (S-ATAF) Aflibercept (Eylea) ELISA
MTB-AFL-QNS-EYLShikari (S-ATAF) w/confirmation Aflibercept (Eylea) ELISA
MTB-CAN-FD-ILAShikari (Q-CAN) Canakinumab (Ilaris) ELISA
MTB-CAN-QLS-ILAShikari (S-ATCAN) Canakinumab (Ilaris) ELISA
MTB-CAN-QNS-ILAShikari (S-ATCAN) w/confirmation Canakinumab (Ilaris) ELISA
MTB-DUR-FD-IMFShikari (Q-DUR) Durvalumab (Imfinzi) ELISA
MTB-DUR-QLS-IMFShikari (S-ATDUR) Durvalumab (Imfinzi) ELISA
MTB-ATE-FD-TECShikari (Q-ATE) Atezolizumab (Tecentriq) ELISA
MTB-ATE-QLS-TECShikari (S-ATAT) Atezolizumab (Tecentriq) ELISA
MTB-DAR-FD-DARShikari (Q-DAR) Daratumumab (Darzalex) ELISA
MTB-DAR-QLS-DARShikari (S-ATDAR) Daratumumab (Darzalex) ELISA
MTB-ABA-FD-OREShikari (Q-ABA) Abatacept (Orencia) ELISA
MTB-ABA-QLS-OREShikari (S-ATAB) Abatacept (Orencia) ELISA
MTB-ABA-QNS-OREShikari (S-ATAB) w/confirmation Abatacept (Orencia) ELISA
MTB-SEC-FD-VERShikari (Q-SEC) Secukinumab (Cosentyx , Verxant) ELISA
MTB-SEC-QLS-VERShikari (S-ATSEC) Secukinumab (Cosentyx , Verxant) ELISA
MTB-EVO-FD-REPShikari (Q-EVO) Evolocumab (Repatha ) ELISA
MTB-EVO-QLS-REPShikari (S-ATEVO) Evolocumab (Repatha ) ELISA
MTB-PAL-FD-SYNShikari (Q-PAL) Palivizumab (Synagis ) ELISA
MTB-PAL-QLS-SYNShikari (S-ATPAL) Palivizumab (Synagis ) ELISA
MTB-PAL-QNS-SYNShikari (S-ATPAL) w/confirmation Palivizumab (Synagis ) ELISA
MTB-IXE-FD-TALShikari (Q-IXE) Ixekizumab (Taltz ) ELISA
MTB-IXE-QLS-TALShikari (S-ATIXE) Ixekizumab (Taltz ) ELISA
MTB-PER-FD-PERShikari (Q-PER) Pertuzumab (Perjeta ) ELISA
MTB-PER-QLS-PERShikari (S-ATPER) Pertuzumab (Perjeta ) ELISA
MTB-RIS-FD-SKYShikari (Q-RIS) Risankizumab (Skyrizi ) ELISA
MTB-RIS-QLS-SKYShikari (S-ATRIS) Risankizumab (Skyrizi ) ELISA
MTB-RIS-QNS-SKYShikari (S-ATRIS) w/confirmation Risankizumab (Skyrizi ) ELISA
MTB-ECU-FD-SOLShikari (Q-ECU) Eculizumab (Soliris ) ELISA
MTB-ECU-QLS-SOLShikari (S-ATEC) Eculizumab (Soliris ) ELISA
MTB-ECU-QNS-SOLShikari (S-ATEC) w/confirmation Eculizumab (Soliris ) ELISA


作為Matriks Biotek在中國的區域代理,艾美捷科技有限公司將為中國客戶提供全面的Matriks Biotek以及客戶訂制化服務。歡迎大家隨時聯系我們。    


Matriks Biotek艾美捷代理

上一篇:Biosynth

下一篇:APExBIO

  • Matriks Biotek:Shikari--ELISA試劑盒

    Matriks Biotek是第一家生產Remsima(英夫利昔單抗生物仿制藥CT-P13) ELISA試劑盒的生物技術公司。試劑盒包括定量游離藥物檢測試劑盒,定量Anti-Remsima檢測試劑盒和Remsima總抗體檢測試劑盒。

    2024-01-29   
  • 高品質保障 成熟的生產研發技術
  • 高性價比 價宜質優,性價比高
  • 高效省心 從購買到使用,放心無憂
  • 安全運輸 完善的保護措施安全運輸

微信掃碼在線客服

微信咨詢

全國免費技術支持

400-6800-868

在線客服
无码国产在线视频2021|国产在线观看麻豆91精品免费|97超级人人免费碰碰频道|人间五月天国产精品|91人人妻人人澡人人爽秒播
<output id="b3vhn"></output><listing id="b3vhn"><output id="b3vhn"></output></listing><p id="b3vhn"><delect id="b3vhn"><address id="b3vhn"></address></delect></p>
<pre id="b3vhn"></pre><p id="b3vhn"><delect id="b3vhn"><address id="b3vhn"></address></delect></p><pre id="b3vhn"><delect id="b3vhn"><listing id="b3vhn"></listing></delect></pre>

<output id="b3vhn"></output><pre id="b3vhn"></pre>
<output id="b3vhn"><menuitem id="b3vhn"></menuitem></output>
<p id="b3vhn"></p>
<p id="b3vhn"></p>

<pre id="b3vhn"><delect id="b3vhn"><listing id="b3vhn"></listing></delect></pre>
<p id="b3vhn"></p>

<p id="b3vhn"></p>

<p id="b3vhn"><delect id="b3vhn"></delect></p>
<p id="b3vhn"><output id="b3vhn"></output></p>
<p id="b3vhn"></p>
<pre id="b3vhn"><p id="b3vhn"><delect id="b3vhn"></delect></p></pre>
<pre id="b3vhn"></pre>

<p id="b3vhn"><menuitem id="b3vhn"></menuitem></p>

<pre id="b3vhn"><output id="b3vhn"><menuitem id="b3vhn"></menuitem></output></pre>

<p id="b3vhn"></p>

<noframes id="b3vhn"><p id="b3vhn"><menuitem id="b3vhn"></menuitem></p>

<p id="b3vhn"><menuitem id="b3vhn"></menuitem></p>